Nuveen California Select Tax-Free Income Portfolio

NYSE:NXC

13.1 (USD) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q22010 Q42010 Q2
Revenue 1.861.8481.8481.8191.7321.7341.7671.7871.8361.8351.8951.5271.8421.9422.0072.0342.1252.1722.2062.2492.2282.2872.3012.322.36900
Cost of Revenue 000000000000.142000000000000000
Gross Profit 1.861.8481.8481.8191.7321.7341.7671.7871.8361.8351.8951.3841.8421.9422.0072.0342.1252.1722.2062.2492.2282.2872.3012.322.36900
Gross Profit Ratio 111111111110.907111111111111100
Reseach & Development Expenses 000000000000000000000000000
General & Administrative Expenses 0.1790.155-0.0680.1570.1660.1730.1770.1790.1730.1850.170.0860.3460.1770.1830.1770.1820.1770.1750.1760.1790.1740.1740.1710.17800
Selling & Marketing Expenses 000000000000000000000000000
SG&A 0.1790.155-0.0680.1570.1660.1730.1770.1790.1730.1850.170.0860.3460.1770.1830.1770.1820.1770.1750.1760.1790.1740.1740.1710.17800
Other Expenses 000000000002.616000000000000000
Operating Expenses 0.1790.1551.2491.5338.010.1730.1770.1352.0941.9662.94-2.6161.4551.7331.9774.9991.0722.5031.6681.3743.4752.7187.0350.6732.99900
Operating Income 1.681.6930.5991.6621.5661.5611.591.6081.6631.651.72541.4961.7651.8241.8571.9421.9962.032.0722.0492.1132.1282.152.19100
Operating Income Ratio 0.9040.9160.3240.9140.9040.90.90.90.9060.8990.912.620.8120.9090.9090.9130.9140.9190.920.9220.9190.9240.9240.9260.92500
Total Other Income Expenses Net -0.4056.53-3.724-1.375-7.845-4.19-0.3510.3142.268-1.7813.1090-1.109-1.5562.161-7.7884.4527.355-1.4931.5513.6552.89-6.8650.8393.17200
Income Before Tax 1.2768.223-3.1250.287-6.279-2.6291.2381.9223.931-0.1314.83540.3870.2093.985-2.9663.1974.6750.5373.6235.7035.003-4.7372.9895.36300
Income Before Tax Ratio 0.6864.45-1.6910.158-3.625-1.5160.7011.0762.14-0.0712.5512.620.210.1081.985-1.4581.5052.1520.2441.6112.562.188-2.0581.2882.26400
Income Tax Expense 000-1.375-7.846000.3142.268-1.7813.1090.854-1.109-1.5562.161-4.8221.2552.68-1.4931.5513.6552.888-6.8690.8353.16700
Net Income 1.2764.1110.9870.287-6.279-2.6291.2381.9223.931-0.1314.83540.3870.2093.985-2.9663.1974.6750.5373.6235.7035.003-4.7372.9895.36300
Net Income Ratio 0.6862.2250.5340.158-3.625-1.5160.7011.0762.14-0.0712.5512.620.210.1081.985-1.4581.5052.1520.2441.6112.562.188-2.0581.2882.26400
EPS 0.21.29-0.490.045-0.98-0.190.190.30.62-0.0210.760.630.0610.0330.62-0.480.50.740.0860.580.90.8-0.760.480.8600
EPS Diluted 0.21.29-0.490.045-0.98-0.190.190.30.62-0.0210.760.630.0610.0330.62-0.480.50.740.0860.580.90.8-0.760.480.8600
EBITDA 04.1130.987-1.375-7.845000.3142.268-1.7813.1094-0.722-1.5560-4.8221.2552.68-1.4931.5513.6552.89-6.8650.8393.16700
EBITDA Ratio 02.2260.534-0.756-4.529000.1761.235-0.971.6412.62-0.392-0.8010-2.3710.5911.234-0.6770.691.641.264-2.9830.3621.33700